Evidence map›Paper›PMID 33303035›Full record

ReviewJournal of biological research (Thessalonike, Greece)2020

Prostate cancer and therapeutic challenges.

Yousef MohammedRabaa Hawsawi, Samar Abdullah Zailaie, Atif Abdulwahab A Oyouni, Othman Rashed Alzahrani, Osama Mohamed Alamer, Saad Ali S Aljohani

Open access · goldAbstract readReview
In one paragraph

Review in Journal of biological research (Thessalonike, Greece), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yousef MohammedRabaa HawsawiSaudi Human Genome Program-Jeddah Satellite Laboratory, Research Center, King Faisal Specialist Hospital and Research Center, MBC-J04, P.O. Box 40047, Jeddah, 21499, Kingdom of Saudi Arabia. hyousef@kfshrc.edu.sa.
Samar Abdullah ZailaieSaudi Human Genome Program-Jeddah Satellite Laboratory, Research Center, King Faisal Specialist Hospital and Research Center, MBC-J04, P.O. Box 40047, Jeddah, 21499, Kingdom of Saudi Arabia.
Atif Abdulwahab A OyouniDepartment of Biology, Faculty of Sciences, University of Tabuk, Tabuk, Kingdom of Saudi Arabia.
Othman Rashed AlzahraniDepartment of Biology, Faculty of Sciences, University of Tabuk, Tabuk, Kingdom of Saudi Arabia.
Osama Mohamed AlamerDepartment of Medical Laboratory Technology, Faculty of Applied Medical Science, University of Tabuk, Tabuk, Kingdom of Saudi Arabia.
Saad Ali S AljohaniDepartment of Basic Medical Sciences, Faculty of Medicine, Al-Rayan Colleges, Almadinah Almunawarah, Kingdom of Saudi Arabia.
University of Tabuk · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer (PC) is the most prevalent type of cancer in men worldwide. In Saudi Arabia, the rate of PC is increasing annually. The sex steroid hormones androgens and their receptors have critical roles in PC development and progression. Additionally, apoptosis-related proteins such as heat-shock proteins are vital molecules in PC development. Steroid hormone-deprivation therapies remain the essential treatment for patients with metastatic PCs; however, acquired resistance to hormone deprivation and the transition to PC androgen independence is a major health obstacle. In this review, we aim to detail the roles of androgens, androgen receptors and sex steroid hormones in inducing apoptosis in PC.

Indexed as

Androgen receptorAndrogensAnti-androgen therapyHeat-shock proteinProstate cancer

Identifiers

PMID33303035
PMCPMC7730758
OpenAlexW3111344069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.